• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类ABC转运蛋白ABCG2的主要单核苷酸多态性(Q141K)变体经历溶酶体和蛋白酶体降解。

Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.

作者信息

Furukawa Tomoka, Wakabayashi Kanako, Tamura Ai, Nakagawa Hiroshi, Morishima Yoshihiro, Osawa Yoichi, Ishikawa Toshihisa

机构信息

Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259-B-60 Nagatsuta, Midori-ku, Yokohama, 226-8501, Japan.

出版信息

Pharm Res. 2009 Feb;26(2):469-79. doi: 10.1007/s11095-008-9752-7. Epub 2008 Oct 29.

DOI:10.1007/s11095-008-9752-7
PMID:18958403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2628956/
Abstract

PURPOSE

Single nucleotide polymorphisms (SNPs) of the ATP-binding cassette (ABC) transporter ABCG2 gene have been suggested to be a significant factor in patients' responses to medication and/or the risk of diseases. We aimed to evaluate the impact of the major non-synonymous SNP Q141K on lysosomal and proteasomal degradations.

METHODS

ABCG2 WT and the Q141K variant were expressed in Flp-In-293 cells by using the Flp recombinase system. Their expression levels and cellular localization was measured by immunoblotting and immunofluorescence microscopy, respectively.

RESULTS

The protein level of the Q141K variant expressed in Flp-In-293 cells was about half that of ABCG2 WT, while their mRNA levels were equal. The protein expression level of the Q141K variant increased about two-fold when Flp-In-293 cells were treated with MG132. In contrast, the protein level of ABCG2 WT was little affected by the same treatment. After treatment with bafilomycin A1, the protein levels of ABCG2 WT and Q141K increased 5- and 2-fold in Flp-In-293 cells, respectively.

CONCLUSIONS

The results strongly suggest that the major non-synonymous SNP Q141K affects the stability of the ABCG2 protein in the endoplasmic reticulum and enhances its susceptibility to ubiquitin-mediated proteasomal degradation.

摘要

目的

三磷酸腺苷结合盒(ABC)转运蛋白ABCG2基因的单核苷酸多态性(SNP)被认为是影响患者药物反应和/或疾病风险的重要因素。我们旨在评估主要非同义SNP Q141K对溶酶体和蛋白酶体降解的影响。

方法

利用Flp重组酶系统在Flp-In-293细胞中表达ABCG2野生型(WT)和Q141K变体。分别通过免疫印迹和免疫荧光显微镜检测它们的表达水平和细胞定位。

结果

在Flp-In-293细胞中表达的Q141K变体的蛋白质水平约为ABCG2 WT的一半,而它们的mRNA水平相等。用MG132处理Flp-In-293细胞后,Q141K变体的蛋白质表达水平增加了约两倍。相比之下,相同处理对ABCG2 WT的蛋白质水平影响很小。用巴弗洛霉素A1处理后,Flp-In-293细胞中ABCG2 WT和Q141K的蛋白质水平分别增加了5倍和2倍。

结论

结果强烈表明,主要非同义SNP Q141K影响ABCG2蛋白在内质网中的稳定性,并增强其对泛素介导的蛋白酶体降解的敏感性。

相似文献

1
Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.人类ABC转运蛋白ABCG2的主要单核苷酸多态性(Q141K)变体经历溶酶体和蛋白酶体降解。
Pharm Res. 2009 Feb;26(2):469-79. doi: 10.1007/s11095-008-9752-7. Epub 2008 Oct 29.
2
Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.泛素介导的人类ABC转运蛋白ABCG2非同义单核苷酸多态性变体的蛋白酶体降解
Biochem J. 2008 May 1;411(3):623-31. doi: 10.1042/BJ20071229.
3
Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.人类ATP结合盒转运蛋白ABCG2非同义单核苷酸多态性的重新评估与功能分类
Cancer Sci. 2007 Feb;98(2):231-9. doi: 10.1111/j.1349-7006.2006.00371.x.
4
Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2.N 连接糖基化的破坏增强了人 ATP 结合盒转运蛋白 ABCG2 的泛素介导的蛋白酶体降解。
FEBS J. 2009 Dec;276(24):7237-52. doi: 10.1111/j.1742-4658.2009.07423.x.
5
Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.分子内二硫键是决定ATP结合盒(ABC)转运蛋白ABCG2蛋白降解命运的关键检查点。
J Biol Chem. 2007 Sep 21;282(38):27841-6. doi: 10.1074/jbc.C700133200. Epub 2007 Aug 8.
6
Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.人类ATP结合盒(ABC)转运蛋白ABCG2基因多态性的功能验证:卟啉转运缺陷等位基因的鉴定
Mol Pharmacol. 2006 Jul;70(1):287-96. doi: 10.1124/mol.106.023556. Epub 2006 Apr 11.
7
In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.与人类ABC转运蛋白ABCG2基因多态性相关的光敏性风险及药物抑制作用的体外评估
Drug Metab Pharmacokinet. 2007 Dec;22(6):428-40. doi: 10.2133/dmpk.22.428.
8
Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.乳腺癌耐药蛋白(BCRP)介导的格列吡嗪转运:C421A/Q141K BCRP 单核苷酸多态性的影响。
Drug Metab Dispos. 2010 May;38(5):740-4. doi: 10.1124/dmd.109.030791. Epub 2010 Feb 16.
9
The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.C421A(Q141K)多态性增强了ATP结合盒转运蛋白ABCG2的3'非翻译区(3'-UTR)依赖性调控。
Biochem Pharmacol. 2016 Mar 15;104:139-47. doi: 10.1016/j.bcp.2016.02.011. Epub 2016 Feb 21.
10
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.单核苷酸多态性导致多药转运蛋白ABCG2的膜定位受损和ATP酶活性降低。
Int J Cancer. 2004 Mar 20;109(2):238-46. doi: 10.1002/ijc.11669.

引用本文的文献

1
Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis.ABCG2基因多态性与他汀类药物所致不良事件的关联:一项荟萃分析。
Cardiovasc Toxicol. 2025 Aug 23. doi: 10.1007/s12012-025-10056-w.
2
Revisiting the Role of the Leucine Plug/Valve in the Human ABCG2 Multidrug Transporter.重新审视亮氨酸塞/阀在人类ABCG2多药转运蛋白中的作用。
Int J Mol Sci. 2025 Apr 24;26(9):4010. doi: 10.3390/ijms26094010.
3
ABCC2 p.R393W variant contributes to Dubin-Johnson syndrome by targeting MRP2 to proteasome degradation.ABCC2 p.R393W变异体通过将多药耐药相关蛋白2(MRP2)靶向蛋白酶体降解,导致杜宾-约翰逊综合征。
eGastroenterology. 2024 Mar 25;2(1):e100039. doi: 10.1136/egastro-2023-100039. eCollection 2024 Jan.
4
ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.ABCG2 多态性与抗逆转录病毒药物相关肝毒性易感性的关系。
Mol Genet Genomic Med. 2024 Mar;12(3):e2362. doi: 10.1002/mgg3.2362. Epub 2024 Mar 7.
5
Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta-Analysis.与非小细胞肺癌铂类化疗反应相关的遗传变异:现场综述和荟萃分析。
Br J Biomed Sci. 2024 Feb 21;81:11835. doi: 10.3389/bjbs.2024.11835. eCollection 2024.
6
Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.遗传多态性作为非小细胞肺癌铂类化疗潜在的药物遗传学生物标志物。
Mol Biol Rep. 2024 Jan 13;51(1):102. doi: 10.1007/s11033-023-08915-2.
7
Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature.从冷冻脑组织中分离微血管的通用方法:神经血管系统的概念验证多组学研究
Brain Behav Immun Health. 2023 Sep 21;34:100684. doi: 10.1016/j.bbih.2023.100684. eCollection 2023 Dec.
8
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.新兴的降尿酸药物和痛风的药物治疗策略:一篇叙述性综述。
Drugs. 2023 Nov;83(16):1501-1521. doi: 10.1007/s40265-023-01944-y. Epub 2023 Oct 11.
9
Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine.基因多态性与个体对右美托咪定的易感性相关。
Front Genet. 2023 Aug 24;14:1187415. doi: 10.3389/fgene.2023.1187415. eCollection 2023.
10
Early evidence indicates that deacetylated sialic acids modulate multi-drug resistance in colon and lung cancers breast cancer resistance protein.早期证据表明,去乙酰化唾液酸可调节结肠癌和肺癌中的多药耐药性——乳腺癌耐药蛋白。
Front Oncol. 2023 Jun 12;13:1145333. doi: 10.3389/fonc.2023.1145333. eCollection 2023.

本文引用的文献

1
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe.乳腺癌耐药蛋白(ABCG2)与药物处置:肠道表达、多态性以及作为体内探针的柳氮磺胺吡啶
Pharmacogenet Genomics. 2008 May;18(5):439-48. doi: 10.1097/FPC.0b013e3282f974dc.
2
Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2.泛素介导的人类ABC转运蛋白ABCG2非同义单核苷酸多态性变体的蛋白酶体降解
Biochem J. 2008 May 1;411(3):623-31. doi: 10.1042/BJ20071229.
3
Dissecting the ER-associated degradation of a misfolded polytopic membrane protein.剖析错误折叠的多聚体膜蛋白的内质网相关降解过程。
Cell. 2008 Jan 11;132(1):101-12. doi: 10.1016/j.cell.2007.11.023.
4
Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.分子内二硫键是决定ATP结合盒(ABC)转运蛋白ABCG2蛋白降解命运的关键检查点。
J Biol Chem. 2007 Sep 21;282(38):27841-6. doi: 10.1074/jbc.C700133200. Epub 2007 Aug 8.
5
Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.癌症患者中ABCG2基因变异与表皮生长因子受体酪氨酸激酶抑制剂药代动力学的关联
Cancer Biol Ther. 2007 Mar;6(3):432-8. doi: 10.4161/cbt.6.3.3763. Epub 2007 Mar 29.
6
Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.人类ATP结合盒转运蛋白ABCG2非同义单核苷酸多态性的重新评估与功能分类
Cancer Sci. 2007 Feb;98(2):231-9. doi: 10.1111/j.1349-7006.2006.00371.x.
7
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.ABCG2的药物遗传学与吉非替尼的不良反应
J Natl Cancer Inst. 2006 Dec 6;98(23):1739-42. doi: 10.1093/jnci/djj469.
8
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.热休克蛋白90辅助伴侣蛋白Aha1的下调可挽救囊性纤维化中囊性纤维化跨膜传导调节因子的错误折叠。
Cell. 2006 Nov 17;127(4):803-15. doi: 10.1016/j.cell.2006.09.043.
9
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.连续质量控制检查点对错误折叠的囊性纤维化跨膜传导调节因子进行分类。
Cell. 2006 Aug 11;126(3):571-82. doi: 10.1016/j.cell.2006.06.041.
10
Human ABC transporter ABCG2 in xenobiotic protection and redox biology.人类ABC转运蛋白ABCG2在异源物质保护和氧化还原生物学中的作用
Drug Metab Rev. 2006;38(3):371-91. doi: 10.1080/03602530600727947.